Collegium Pharmaceutical Inc (COLL)
Quick ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 70,565 | 38,960 | 172,894 | 228,610 | 238,947 | 258,532 | 283,749 | 269,480 | 173,688 | 134,126 | 122,722 | 106,698 | 186,426 | 193,241 | 202,771 | 182,790 | 174,116 | 165,423 | 145,678 | 116,178 |
| Short-term investments | US$ in thousands | 92,198 | 80,997 | 98,737 | 89,438 | 71,601 | 46,033 | 41,721 | — | 0 | — | — | — | — | — | — | — | — | — | — | — |
| Receivables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 10,000 | 459,426 | 461,717 | 446,436 | 457,915 | 464,612 | 435,058 | 412,702 | 270,114 | 414,497 | 415,094 | 373,573 | 230,399 | 268,973 | 226,843 | 230,168 | 191,226 | 242,437 | 252,111 | 244,374 |
| Quick ratio | 16.28 | 0.26 | 0.59 | 0.71 | 0.68 | 0.66 | 0.75 | 0.65 | 0.64 | 0.32 | 0.30 | 0.29 | 0.81 | 0.72 | 0.89 | 0.79 | 0.91 | 0.68 | 0.58 | 0.48 |
December 31, 2024 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($70,565K
+ $92,198K
+ $—K)
÷ $10,000K
= 16.28
The quick ratio of Collegium Pharmaceutical Inc has shown fluctuations over the years. It started at a relatively low level of 0.48 as of March 31, 2020, indicating that the company had only $0.48 in liquid assets available to cover each $1 of current liabilities. The ratio gradually increased to 0.91 by December 31, 2020, suggesting an improvement in the company's ability to meet its short-term obligations with its quick assets.
However, the quick ratio decreased in the following periods, reaching its lowest point of 0.26 as of September 30, 2024. This significant drop may raise concerns about Collegium Pharmaceutical Inc's liquidity position and its ability to meet its short-term liabilities from its most liquid assets.
The sudden spike to 16.28 on December 31, 2024, seems to be an outlier in the data provided and may be due to unusual circumstances or errors in reporting. It is advised to further investigate this anomaly to ensure the accuracy of the financial information.
Overall, the trend in Collegium Pharmaceutical Inc's quick ratio indicates some volatility in its liquidity position, emphasizing the importance of monitoring the company's ability to meet its short-term obligations with readily available assets.
Peer comparison
Dec 31, 2024